mimv4q6i | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/mimv4q6i_hasAnnotation_C0003374>
?:creator	<https://research.tib.eu/covid-19/entity/Liuzzo%2C_Giovanna%3B_Patrono%2C_Carlo>
?:doi	<https://research.tib.eu/covid-19/entity/10.1093/eurheartj/ehaa935>
?:doi	10.1093/eurheartj/ehaa935
?:journal	Eur_Heart_J
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/1e22d8812900503fa2ae2ffa25a8172219d31aed.json
?:pmc_json_files	document_parses/pmc_json/PMC7717256.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7717256>
?:pmid	<https://research.tib.eu/covid-19/entity/33219663.0>
?:pmid	33219663.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/1e22d8812900503fa2ae2ffa25a8172219d31aed>
?:source	Medline; PMC
?:title	The widely promoted antimalarial drug hydroxychloroquine confers no mortality benefit in hospitalized patients with COVID-19: comment on the ‘Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19’
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-21

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/mimv4q6i>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/mimv4q6i>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all